Herbas VPB

Print
EN | LT
LT - ENGINEERED ANTIBODY CONSTANT REGIONS FOR SITE-SPECIFIC CONJUGATION AND METHODS AND USES THEREFOR
EN - ENGINEERED ANTIBODY CONSTANT REGIONS FOR SITE-SPECIFIC CONJUGATION AND METHODS AND USES THEREFOR

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28
C07K 16/32
A61K 38/08
A61K 47/68
C07K 16/30
European patent
(11) Number of the document 2794653
(13) Kind of document T
(96) European patent application number 12823018.2
Date of filing the European patent application 2012-12-19
(97) Date of publication of the European application 2014-10-29
(45) Date of publication and mention of the grant of the patent 2019-03-13
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/IB2012/057491
Date 2012-12-19
PCT application publication
(87) Number WO 2013/093809
Date 2013-06-27
Priority applications
(30) Number Date Country code
201161580169 P 2011-12-23 US
Inventors
(72)
MARQUETTE, Kimberly, US
BENNETT, Eric, US
TCHISTIAKOVA, Lioudmila, US
TUMEY, L. Nathan, US
BIKKER, Jack, US
CALABRO, Valerie, FR
GRAZIANI, Edmund, US
Grantee
(73) Pfizer Inc., 235 East 42nd Street, New York, NY 10017, US
Title
(54) ENGINEERED ANTIBODY CONSTANT REGIONS FOR SITE-SPECIFIC CONJUGATION AND METHODS AND USES THEREFOR
  ENGINEERED ANTIBODY CONSTANT REGIONS FOR SITE-SPECIFIC CONJUGATION AND METHODS AND USES THEREFOR
Last update date 2021-04-30